Results 1 to 10 of about 459,876 (311)

An Updated Overview of the Magnetic Resonance Imaging of Brain Iron in Movement Disorders

open access: yesBehavioural Neurology, 2022
Brain iron load is one of the most important neuropathological hallmarks in movement disorders. Specifically, the iron provides most of the paramagnetic metal signals in the brain and its accumulation seems to play a key role, although not completely ...
Nicola Tambasco   +7 more
doaj   +1 more source

A single centre prospective study of three device-assisted therapies for Parkinson’s disease

open access: yesnpj Parkinson's Disease, 2023
Comparative studies assessing outcomes with the three device-assisted therapies could help to individualise treatment for patients living with Parkinson’s disease.
Hugo Morales-Briceño   +11 more
doaj   +1 more source

A systematic review of associations between common SNCA variants and clinical heterogeneity in Parkinson’s disease

open access: yesnpj Parkinson's Disease, 2021
There is great heterogeneity in both the clinical presentation and rate of disease progression among patients with Parkinson’s disease (PD). This can pose prognostic difficulties in a clinical setting, and a greater understanding of the risk factors that
Camilla Christina Pedersen   +5 more
doaj   +1 more source

The impact of recurrent Covid-19 waves on patients with Functional Movement Disorders: A follow-up study

open access: yesClinical Parkinsonism & Related Disorders, 2022
Background: Functional Movement Disorders (FMDs) might exacerbate in stressful conditions. As the global health emergency due to Covid-19 rise and multiple waves hit the Italian population, the recurrent severe restrictions’ periods imposed could ...
Angela Sandri   +4 more
doaj   +1 more source

Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA mutation carriers

open access: yesnpj Parkinson's Disease, 2022
Non-manifesting carriers (NMCs) of Parkinson’s disease (PD)-related mutations such as LRRK2 and GBA are at an increased risk for developing PD. Dopamine transporter (DaT)-spectral positron emission computed tomography is widely used for capturing ...
Amgad Droby   +13 more
doaj   +1 more source

Validation and assessment of preanalytical factors of a fluorometric in vitro assay for glucocerebrosidase activity in human cerebrospinal fluid

open access: yesScientific Reports, 2020
Lysosomal dysfunction is an emerging feature in the pathology of Parkinson’s disease and Dementia with Lewy bodies. Mutations in the GBA gene, encoding the enzyme Glucocerebrosidase (GCase), have been identified as a genetic risk factor for these ...
Linn Oftedal   +4 more
doaj   +1 more source

Movement Disorders in Metabolic Disorders [PDF]

open access: yesCurrent Neurology and Neuroscience Reports, 2019
We provide a review of the movement disorders that complicate selected metabolic disorders, including the abnormal movements that may appear during or after their treatment.Movement disorders may be underrecognized when arising in the context of a broad range of metabolic disorders.
Pedroso, José Luiz   +2 more
openaire   +3 more sources

Sexual Dysfunctions in Parkinson’s Disease and Their Influence on Partnership—Data of the PRISM Study

open access: yesBrain Sciences, 2022
Background: Sexual dysfunctions (SD) are common but underreported in Parkinson’s disease (PD) and have negative impacts on the quality of life (QoL) and partnership.
Thomas Kinateder   +5 more
doaj   +1 more source

Eye movement abnormalities in movement disorders [PDF]

open access: yesClinical Parkinsonism & Related Disorders, 2019
The visual system represents the most well-developed sensory system in humans, who are highly dependent on vision for organized response to their environment. The region of eye that is responsible for sharp central vision is the fovea. Thus, to see the world, images of objects of interest should fall on fovea.
Lal, Vivek, Truong, Daniel
openaire   +4 more sources

Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) among Patients at a Movement Disorders Center

open access: yesGeriatrics, 2020
It is not established whether SARS-CoV-2 (COVID-19) patients with movement disorders, are at greater risk for more serious outcomes than the larger COVID-19 population beyond the susceptibility associated with greater age.
Joy Antonelle de Marcaida   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy